{"id":"W1971890855","doi":"10.2165/00019053-200119090-00004","title":"Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; Heart and Stroke Foundation of Canada","keywords":"Medicine; Ischaemic stroke; Stroke (engine); Cohort; Tissue plasminogen activator; Thrombolysis; Quality-adjusted life year; Clinical trial; Internal medicine; Cost effectiveness; Emergency medicine; Physical therapy; Pediatrics; Ischemia; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002419981,0.0002282895,0.0007162198,0.0003189825,0.00004740534,0.00001221868,0.0002287811,0.00008022725,0.001270806],"category_scores_gemma":[0.0000174671,0.0002261212,0.0003473993,0.0002440129,0.00007070533,0.000127768,0.00007491864,0.0001349314,0.00002327374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001660187,"about_ca_system_score_gemma":0.00007032671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003653845,"about_ca_topic_score_gemma":0.000004355241,"domain_scores_codex":[0.9986321,0.0000180102,0.0004854672,0.000410551,0.0001151273,0.0003386953],"domain_scores_gemma":[0.9989007,0.0001344356,0.000263763,0.0004444214,0.00008687103,0.0001698148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008321021,0.0008616775,0.1258733,0.0001106459,0.05238616,0.00003387704,0.0007379593,0.0004604584,0.5583277,0.00007462365,0.0927459,0.1600666],"study_design_scores_gemma":[0.00481484,0.0001656235,0.006304811,0.000005239336,0.00642358,0.0000105736,0.0001287918,0.02316491,0.5261941,0.00000695136,0.4325545,0.0002261523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854909,0.0001885421,0.006088353,0.0009036255,0.0002177749,0.001560296,0.0006701376,0.00005634116,0.004824081],"genre_scores_gemma":[0.9913238,0.001498479,0.002367194,0.001627943,0.0002000768,0.0001916541,0.0002680889,0.0000404671,0.002482278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3398086,"threshold_uncertainty_score":0.9996422,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04840456463649569,"score_gpt":0.3762509053883046,"score_spread":0.327846340751809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}